Unravelling the convoluted biological roles of Type I interferons (IFN-Is) in infection and immunity: a way forward for therapeutics and vaccine design

It has been well-established that type I interferons (IFN-Is) have pleiotropic effects and play an early central role in the control of many acute viral infections. However, their pleiotropic effects are not always beneficial to the host and in fact several reports suggest that the induction of IFN-...

Full description

Bibliographic Details
Main Authors: Danushka Kumara Wijesundara, Yang eXi, Charani eRanasinghe
Format: Article
Language:English
Published: Frontiers Media S.A. 2014-08-01
Series:Frontiers in Immunology
Subjects:
Online Access:http://journal.frontiersin.org/Journal/10.3389/fimmu.2014.00412/full
id doaj-6b63a981768941aaaa635fc146785cf7
record_format Article
spelling doaj-6b63a981768941aaaa635fc146785cf72020-11-24T20:49:06ZengFrontiers Media S.A.Frontiers in Immunology1664-32242014-08-01510.3389/fimmu.2014.00412103647Unravelling the convoluted biological roles of Type I interferons (IFN-Is) in infection and immunity: a way forward for therapeutics and vaccine designDanushka Kumara Wijesundara0Danushka Kumara Wijesundara1Yang eXi2Charani eRanasinghe3The Basil Hetzel InstituteThe John Curtin School of Medical ResearchLung and Allergy Research CentreThe John Curtin School of Medical ResearchIt has been well-established that type I interferons (IFN-Is) have pleiotropic effects and play an early central role in the control of many acute viral infections. However, their pleiotropic effects are not always beneficial to the host and in fact several reports suggest that the induction of IFN-Is exacerbate disease outcomes against bacterial and chronic viral infections. In this brief review, we probe into this mystery and try to develop answers based on past and recent studies evaluating the roles of IFN-Is in infection and immunity as this is vital for developing effective IFN-Is based therapeutics and vaccines. We also discuss the biological roles of an emerging IFN-I, namely IFN-ε, and discuss its potential use as a mucosal therapeutic and/or vaccine adjuvant. Overall, we anticipate the discussions generated in this review will provide new insights for better exploiting the biological functions of IFN-Is in developing efficacious therapeutics and vaccines in the future.http://journal.frontiersin.org/Journal/10.3389/fimmu.2014.00412/fullhuman immunodeficiency virusType I InterferonsIFN-εvaccine adjuvantsInterferon immunity
collection DOAJ
language English
format Article
sources DOAJ
author Danushka Kumara Wijesundara
Danushka Kumara Wijesundara
Yang eXi
Charani eRanasinghe
spellingShingle Danushka Kumara Wijesundara
Danushka Kumara Wijesundara
Yang eXi
Charani eRanasinghe
Unravelling the convoluted biological roles of Type I interferons (IFN-Is) in infection and immunity: a way forward for therapeutics and vaccine design
Frontiers in Immunology
human immunodeficiency virus
Type I Interferons
IFN-ε
vaccine adjuvants
Interferon immunity
author_facet Danushka Kumara Wijesundara
Danushka Kumara Wijesundara
Yang eXi
Charani eRanasinghe
author_sort Danushka Kumara Wijesundara
title Unravelling the convoluted biological roles of Type I interferons (IFN-Is) in infection and immunity: a way forward for therapeutics and vaccine design
title_short Unravelling the convoluted biological roles of Type I interferons (IFN-Is) in infection and immunity: a way forward for therapeutics and vaccine design
title_full Unravelling the convoluted biological roles of Type I interferons (IFN-Is) in infection and immunity: a way forward for therapeutics and vaccine design
title_fullStr Unravelling the convoluted biological roles of Type I interferons (IFN-Is) in infection and immunity: a way forward for therapeutics and vaccine design
title_full_unstemmed Unravelling the convoluted biological roles of Type I interferons (IFN-Is) in infection and immunity: a way forward for therapeutics and vaccine design
title_sort unravelling the convoluted biological roles of type i interferons (ifn-is) in infection and immunity: a way forward for therapeutics and vaccine design
publisher Frontiers Media S.A.
series Frontiers in Immunology
issn 1664-3224
publishDate 2014-08-01
description It has been well-established that type I interferons (IFN-Is) have pleiotropic effects and play an early central role in the control of many acute viral infections. However, their pleiotropic effects are not always beneficial to the host and in fact several reports suggest that the induction of IFN-Is exacerbate disease outcomes against bacterial and chronic viral infections. In this brief review, we probe into this mystery and try to develop answers based on past and recent studies evaluating the roles of IFN-Is in infection and immunity as this is vital for developing effective IFN-Is based therapeutics and vaccines. We also discuss the biological roles of an emerging IFN-I, namely IFN-ε, and discuss its potential use as a mucosal therapeutic and/or vaccine adjuvant. Overall, we anticipate the discussions generated in this review will provide new insights for better exploiting the biological functions of IFN-Is in developing efficacious therapeutics and vaccines in the future.
topic human immunodeficiency virus
Type I Interferons
IFN-ε
vaccine adjuvants
Interferon immunity
url http://journal.frontiersin.org/Journal/10.3389/fimmu.2014.00412/full
work_keys_str_mv AT danushkakumarawijesundara unravellingtheconvolutedbiologicalrolesoftypeiinterferonsifnisininfectionandimmunityawayforwardfortherapeuticsandvaccinedesign
AT danushkakumarawijesundara unravellingtheconvolutedbiologicalrolesoftypeiinterferonsifnisininfectionandimmunityawayforwardfortherapeuticsandvaccinedesign
AT yangexi unravellingtheconvolutedbiologicalrolesoftypeiinterferonsifnisininfectionandimmunityawayforwardfortherapeuticsandvaccinedesign
AT charanieranasinghe unravellingtheconvolutedbiologicalrolesoftypeiinterferonsifnisininfectionandimmunityawayforwardfortherapeuticsandvaccinedesign
_version_ 1716806731578736640